We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

January 27, 2021

This is the Future of Digital Therapeutics

Reports
HealthXL Research Team
&
Brian Dolan

Sneak peek into our upcoming report

We are excited to give you a sneak peek into our upcoming report on Prescription Digital Therapeutics. 

In 2018, we released our first report on Digital Therapeutics (DTx), aiming to get behind the hype and dig into the DTx landscape, business models, regulation, reimbursement, evidence, and adoption. In the past two years, a lot has happened. A wide variety of companies have co-opted the term “digital therapeutics” to describe their digital health offerings. This report seeks to cut through some of that noise by focusing on a smaller subset of this group: prescription digital therapeutics (PDT).

We are excited to announce that for our 2021 PDT report, we are collaborating with Brian Dolan of Exits & Outcomes (E&O). E&O is a digital health research and media company led by Brian, who also founded MobiHealthNews back in 2008. 

The objective of this HealthXL- E&O Report is to deep dive into one subsegment of DTx that has enormous potential: prescription products. We shine a light on clinical validation, adoption, investments, reimbursement and regulation. 

This report contains key examples of PDT applications, industry implications and a critical viewpoint of the current reality of the DTx environment and those which must be addressed in order to truly deliver on the DTx promise in terms of optimized health outcomes. 

What can you expect to see? 


Investment / Solutions Landscape

We examine how the investment landscape for PDTs has changed over 2018-2020.  It is clear that COVID-19 has hugely increased investments/partnerships within the digital health space, PDTs included! The top funded PDT company of 2020 was Biofourmis, obtaining a whopping $100 million in investments.

Source: Portal.HealthXL.com


Business Models and Pricing

Business models and pricing for digital therapeutics are some of the most sought after details among large corporations, investors and startups alike. In this section of the report we outline different PDT business models which include those that follow the more traditional pharmaceutical pathways to sell their products, and newly emerging models which are leveraging telemedicine to facilitate D2C access. We also take a look at the pricing of PDTs which are currently available on the market.

Clinical and Economic Outcomes

Only 27% of PDTs have published RCTs to validate their product offerings. We compare and contrast the current frameworks that support the validation of PDTs [NICE, FDA, TGA, DIGA], and dig into the rigor of evidence provided for these products vs traditional pharmaceutical agents. We also discuss the use of digital endpoints (or lack thereof) in the validation of these products.

Regulatory Environment, Reimbursement and Prescription Pathways


The report digs deep into the regulatory environment and prescription pathways for PDTs in both the US and the EU. We also assess the reimbursement landscape for PDTs across the globe - while developments in the US remain thin, the EU and Japan appear to be leading the charge in the reimbursement space. 

Source: Portal.HealthXL.com


Adoption and Enablement

Prescription capabilities remain a key challenge in the adoption of PDTs, although Germany and Belgium are spearheading change within this space. In the report we take a deep dive into the adoption and enablement of PDTs, fleshing out regional differences and highlighting companies that are shaking up the distribution chain.


The Future of PDT

PDTs are quickly emerging as one of the most spoken about areas of digital health, although it would appear that many barriers remain for the widespread adoption of these technologies. What needs to happen in politics, within the FDA, within PBMs, in the minds of physicians and consumers to move the needle? We gaze into the crystal ball.


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Webinar: Prescription DTx - the future of DTx

13th May @ 11:00AM EDT

Join us for this Webinar as we present the key findings from our HealthXL - Exits & Outcomes PDT Report followed by a panel discussion. Apply promptly to listen and learn from thought leaders in the industry.

Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Richie Bavasso
Richie Bavasso
Co-Founder, nQ Medical
Featuring
Eugene Borukhovich
Eugene Borukhovich
Chairman and COO of YourCoach.Health
Richie Bavasso
Richie Bavasso
Co-Founder, nQ Medical
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Measuring DTx efficacy and safety

18th May @ 11:30AM EDT

Join this meeting to discuss with other thought leaders the best practices to measure efficacy and safety of DTx. This is a great opportunity to connect with peers and meet new people.

Featuring
Matthew Prime
Matthew Prime
Global Head of Evidence Generation at Roche
Pedro Maurício
Pedro Maurício
SaMD and DTx Consultant, Altran
Featuring
Matthew Prime
Matthew Prime
Global Head of Evidence Generation at Roche
Pedro Maurício
Pedro Maurício
SaMD and DTx Consultant, Altran
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass: The Regulation of DTx in the US

19th May @ 10:30AM EDT

Join us in this Masterclass led by Amalgam as we discuss the regulation of DTx in the US. Apply now to listen, learn and gain valuable insights from thought leaders in this space.

Featuring
Jason Brooke
Jason Brooke
General Counsel and VP of Regulatory and Quality, AmalgamRx
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Jason Brooke
Jason Brooke
General Counsel and VP of Regulatory and Quality, AmalgamRx
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx opportunities in SE Asia

20th May @ 9:00AM EDT

Join us for this Digital Health meeting as we discuss DTx opportunities in SE Asia. Apply now to secure your place in this 75-minute session, which is guaranteed to be filled with interesting conversation and valuable insights.

Featuring
Louis Payet
Louis Payet
VP Business Development, Commercial Solutions at Zuellig Pharma
John Gordon
John Gordon
Digital Innovation Lab Lead - International Markets at Pfizer
Featuring
Louis Payet
Louis Payet
VP Business Development, Commercial Solutions at Zuellig Pharma
John Gordon
John Gordon
Digital Innovation Lab Lead - International Markets at Pfizer

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Ageing in Place for Older Adults that Need Daily Assistance

11th May @ 10:30AM EDT

Join our Digital Health Meeting focused on ageing in place for older adults that need daily assistance. This meeting is the 1st session of a series of events focused on digital health for ageing in place. Apply now to secure your place in the discussion.

Featuring
Brian Kaskie
Brian Kaskie
Associate Professor, University of Iowa
Kerry Burnright, PhD
Kerry Burnright, PhD
Founder, The Gerontologist Inc
Featuring
Brian Kaskie
Brian Kaskie
Associate Professor, University of Iowa
Kerry Burnright, PhD
Kerry Burnright, PhD
Founder, The Gerontologist Inc
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

Automated Virtual Care platforms in Health Systems.

11th May @ 11:00AM EDT

Join our Digital Health Meeting focused on automated Virtual Care platforms in Health Systems. This 75 minute session is guaranteed to be filled with interesting debate and great conversation. Apply now to secure your place in the discussion.

Featuring
Murray Brozinsky
Murray Brozinsky
Chief Executive Officer at Conversa Health
Zenobia Brown
Zenobia Brown
VP and Medical Director, Northwell Health
Featuring
Murray Brozinsky
Murray Brozinsky
Chief Executive Officer at Conversa Health
Zenobia Brown
Zenobia Brown
VP and Medical Director, Northwell Health
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery
Telemedicine & Virtual Care Delivery

RPM for Covid patients and other respiratory diseases

12th May @ 11:30AM EDT

Join us in this Digital Health Meeting as we discuss the current state of RPM for Covid patients and other respiratory diseases. Great opportunity to hear valuable insights from thought leaders in the industry and connect with peers.

Featuring
Yosef Safi Harb
Yosef Safi Harb
Founder, Happitech
Eamonn Costello
Eamonn Costello
CEO, patientMpower
Featuring
Yosef Safi Harb
Yosef Safi Harb
Founder, Happitech
Eamonn Costello
Eamonn Costello
CEO, patientMpower
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

Getting Physicians to use and trust Digital Health Data

13th May @10:30AM EDT

Join our Digital Health Meeting focused on the topic of getting Physicians to use and trust Digital Health Data. Apply promptly to get involved in the conversation, network with peers and share your thoughts on the topic.

Featuring
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Doina Sirbu
Doina Sirbu
Medical Device Innovation Lead, UCB
Featuring
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Doina Sirbu
Doina Sirbu
Medical Device Innovation Lead, UCB

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.